Elimination of leukemia in the absence of lethal graft versus host disease after allogeneic bone marrow transplantation.

被引：0
|
作者：
Drobyski, WR
Gendelman, M
Vodanovic-Jankovic, S
Gorski, J
机构：
[1] Med Coll Wisconsin, Bone Marrow Transplant Program, Milwaukee, WI 53226 USA
[2] Blood Res Inst, Milwaukee, WI USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3236
引用
收藏
页码：819A / 819A
页数：1
相关论文
共 50 条
  • [31] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [32] GRAFT-VERSUS-LEUKEMIA AFTER SECOND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    AOKI, Y
    TAKAHASHI, S
    OKAMOTO, S
    ASANO, S
    BLOOD, 1994, 84 (11) : 3983 - 3983
  • [33] COMBINATION OF CYCLOSPORINE AND METHOTREXATE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA
    MRSIC, M
    LABAR, B
    BOGDANIC, V
    NEMET, D
    PAVLETIC, Z
    PLAVSIC, F
    DOBRIC, I
    MARUSIC, M
    FRANCETIC, I
    KASTELAN, A
    KALENIC, S
    VRTAR, M
    MARKULINGRGIC, L
    AURER, I
    BONE MARROW TRANSPLANTATION, 1990, 6 (02) : 137 - 141
  • [34] Bone Scintigraphy Pattern of Joint Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation
    Zsigmond, Reka
    Ungureanu, Constantin
    Blagosklonov, Oleg
    Biancheri, Ingrid
    Angoue, Orland
    Runge, Michel
    Wendling, Daniel
    Larosa, Fabrice
    Paycha, Frederic
    Boulahdour, Hatem
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (01) : 20 - 23
  • [35] Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation
    Rettig, MP
    Ritchey, JK
    Prior, JL
    Haug, JS
    Piwnica-Worms, D
    DiPersio, JF
    JOURNAL OF IMMUNOLOGY, 2004, 173 (06): : 3620 - 3630
  • [36] IMPACT OF HLA DISPARITIES ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA REACTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    JACOBSEN, N
    JAKOBSEN, B
    MADSEN, H
    LUND, B
    VINDELOV, L
    GEISLER, C
    HEILMANN, C
    RUSSELL, L
    LAMM, L
    SVEJGAARD, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 862 - 862
  • [37] Outcome of severe graft versus host disease in pediatric patients with nonmalignant diseases after allogeneic bone marrow transplantation. A single center experience
    Zaidman, Irina
    Grisariu, Sigal
    Avni, Batia
    Even-Or, Ehud
    Shadur, Bella
    Nasereddin, Adeeb
    Stepensky, Polina
    BONE MARROW TRANSPLANTATION, 2019, 54 : 302 - 303
  • [38] Mycophenolate mofetil, cyclosporine and methotrexate as acute graft versus host disease prophylaxis after matched unrelated donor allogeneic bone marrow transplantation.
    Huang, H
    Lin, MF
    Lee, ZD
    Meng, HT
    Qian, WB
    Yan, LX
    Cai, Z
    BLOOD, 2000, 96 (11) : 361B - 361B
  • [39] Graft Versus Host Disease After Intestinal Transplantation.
    Vrakas, G.
    Arantes, R.
    Nasralla, D.
    Reddy, S.
    Friend, P.
    Giele, H.
    Vaidya, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 869 - 869
  • [40] Graft Versus Host Disease After Intestinal Transplantation.
    Vrakas, G.
    Arantes, R.
    Nasralla, D.
    Reddy, S.
    Friend, P.
    Giele, H.
    Vaidya, A.
    TRANSPLANTATION, 2014, 98 : 869 - 869
12345